Implementation of drug pricing provisions related to H.R. 5376 (P.L. 117-169), The Inflation Reduction Act. Issues related to safe mobility. Issues related to payment for prescription drugs. Issues concerning drug shortages.
Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes. Monitor issues related to OECD Pillar 2.
Monitored issues related to pharmaceutical prices. Issues regarding the pharmaceutical and medical device supply chain. Monitored issues concerning drug shortages. Issues concerning the reauthorization of Pandemic and All-Hazards Preparedness and Response Act (PAHPA). Monitored AI issues. Cybersecurity issues and S. 4939, Countering CCP Act. Issues concerning emergency preparedness and essential medical supplies. Issues concerning regulatory reforms.
Issues related to tariffs.
H.R. 8800 / S. 4784, the FY27 National Defense Authorization Act, as it relates to right to repair, and the ability of government contractors to pay dividends and buy back stock.